Johnson & Johnson's Fiscal Year is From January To December - All Figures are in Percent.
The item "Funds-From-Operation-To-Total-Debt" stands at 52.85 percent as of 09/30/2025.
As of the end of Johnson & Johnson's third quarter, the item "Funds From Operation To Total Debt" stands at 52.85 Percent. This represents an increase of 7.49 percentage points compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -17.48 percentage points compared to the value the year prior.
The 1 year change in percentage points is -17.48.
The 3 year change in percentage points is -14.52.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Funds From Operation To Total Debt | 905,699,262,464.00 |
![]() | AbbVie Inc - Funds From Operation To Total Debt | 399,570,305,024.00 |
![]() | Roche Holding AG - Funds From Operation To Total Debt | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Funds From Operation To Total Debt | 280,205,508,085.11 |
![]() | Novartis AG - Funds From Operation To Total Debt | 255,096,620,580.91 |